A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome

NCT06304103 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: AND017

Sponsor

Kind Pharmaceuticals LLC